KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
Simon Gleave, Partner of KPMG China, and Harry Hughes, manager of KPMG China, discuss the developments and implications of microfinance in China.
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.
Sector Studies - These studies feature the industry insights and latest developments of specific sectors in China.